Generate Biomedicines says AI could make biology programmable by generating and testing drug hypotheses at machine scale.

Nvidia Corporation (NVDA), the world’s dominant supplier of AI chips, is making a strong push into the software that runs on them. The company a...

Generate Biomedicines says AI could make biology programmable by generating and testing drug hypotheses at machine scale.